Effects of HCV on Basal and Tat-Induced HIV LTR Activation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sengupta, Satarupa ^a   Powell, Eleanor ^a   Kong, Ling ^a   Blackard, Jason T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; PYRROLIDINE DITHIOCARBAMATE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE COURSE; GENE ACTIVATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACELLULAR SIGNALING; LIVER CELL; LONG TERMINAL REPEAT; MIXED INFECTION; NONHUMAN; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; VIRION; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS TRANSCRIPTION;

BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; COINFECTION; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL CORE PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84878893316     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064956     Document Type: Article

References (85)

1. Alter M, (2007) Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology 13: 2436-2441.
2. Lavanchy D, (2009) The global burden of hepatitis C. Liver International. 29: 74-81.
3. Alter M, Druszon-Moran D, Nainan O, McQuillan G, Gao F, et al. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine 341: 556-562.
4. Sherman K, Rouster S, Chung R, Rajicic N, (2002) Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS clinical trials groups. Clinical Infectious Diseases 34: 831-837.
5. Kim AY, Chung R, (2009) Coinfection with HIV-1 and HCV- a one-two punch. Gastroenterology 137: 795-814.
6. Daar ES, Lynn H, Donfield S, Gomperts E, O'Brien SJ, et al. (2001) Hepatitis C viral load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. Journal of Infectious Diseases 193: 589-595.
7. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, et al. (2000) Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356: 1800-1805.
8. Braitstein P, Justice A, Bangsberg DR, Yip B, Alfonso V, et al. (2006) Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS 20: 323-331.
9. Piroth L, Grappin M, Cuzin L, Mouton Y, Bouchard O, et al. (2000) Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients. Journal of Viral Hepatitis 7: 302-308.
10. Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, et al. (1998) Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 12: 381-388.
11. Macias J, Pineda J, Lozano F, Corzo J, Ramos A, et al. (2003) Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naive patients coinfected with human immunodeficiency virus and hepatitis C virus. European Journal of Clinical Microbiology & Infectious Diseases 22: 675-680.
12. Anderson K, Guest J, Rimland D, (2004) Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta Cohort Study. Clinical Infectious Diseases 39: 1507-1513.
13. Backus LI, Phillips BR, Boothroyd DB, Mole LA, Burgess J, et al. (2005) Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 39: 613-619.
14. Crotti A, Chiara GD, Ghezzi S, Lupo R, Jeeninga RE, et al. (2007) Heterogeneity of signal transducer and activator of transcription binding sites in the long-terminal repeats of distinct HIV-1 subtypes. Open Virology Journal 1: 26-32.
15. De Baar MP, De Ronde A, Berkhout B, Cornelissen M, van der Horn KH, et al. (2000) Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site. AIDS Research and Human Retroviruses 16: 499-504.
16. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, De Baar M, Verhoef K, et al. (2000) Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. Journal of Virology. 74: 3740-3751.
17. Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, et al. (1997) Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. Journal of Virology 71: 8657-8665.
18. Montano MA, Nixon CP, Ndung'u T, Bussmann H, Novitsky VA, et al. (2000) Elevated tumor necrosis factor-a activation of human immunodeficiency virus type 1 subtype C in southern Africa is associated with an NF-kB enhancer gain-of-function. Journal of Infectious Diseases 181: 76-81.
19. Verhoef K, Sanders R, Fontaine V, Kitajima S, Berkhout B, (1999) Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kB enhancer element into a GABP binding site. Journal of Virology 73: 1331-1340.
20. Radkowski M, Bednarska A, Horban A, Stanczak J, Wilkinson J, et al. (2004) Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-a and interleukin 8. Journal of General Virology 85: 47-59.
21. Laskus T, Radkowski M, Piasek A, Nowicki M, Horban A, et al. (2000) Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. Journal of Infectious Diseases 181: 442-448.
22. Zignego AL, Giannini C, Monti M, Gragnani L, (2007) Hepatitis C virus lymphotropism: lessons from a decade of studies. Digestive and Liver Disease 39: S38-S45.
23. Pham TN, Macparland SA, Coffin CS, Lee SS, Bursey FR, et al. (2005) Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. Journal of General Virology 86: 657-666.
24. Kondo Y, Sung VM, Machida K, Liu M, Lai M, (2007) Hepatitis C virus infects T cells and affects interferon-g signaling in T cell lines. Virology 361: 161-173.
25. Xiao P, Usami O, Suzuki Y, Ling H, Shimizu N, et al. (2008) Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4. AIDS 22: 1749-1757.
26. Iser DM, Warner N, Revill PA, Solomon A, Wightman F, et al. (2010) Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen. Journal of Virology 84: 5860-5867.
27. Kong L, Cardona Maya W, Moreno-Fernandez ME, Ma G SM, Sherman KE, et al. (2012) Low-level HIV infection of hepatocytes. Virology Journal 9: 157.
28. Fromentin R, MR T, Tremblay M, (2010) Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1/LFA-1-dependent mechanism. Virology 398: 168-175.
29. Bruno R, Galastri S, Sacchi P, Cima S, Caligiuri A, et al. (2010) gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut 59: 513-520.
30. Tuyama AC, Hong F, Saiman Y, Wang C, Ozkok D, et al. (2010) Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 52: 612-622.
31. Vlahakis S, Villasis-Keever A, Gomez T, Bren G, Paya C, (2003) Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. Journal of Infectious Diseases 188: 1455-1460.
32. Munshi N, Balasubramanian A, Koziel M, Ganju R, Groopman J, (2003) Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. Journal of Infectious Diseases 188: 1192-1204.
33. Balasubramanian A, Koziel M, Groopman J, Ganju R, (2005) Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. Clinical Infectious Diseases 41: S32-S37.
34. Babu CK, Suwansrinon K, Bren GD, Badley AD, Rizza S, (2009) HIV induces TRAIL sensitivity in hepatocytes. PLoS One 4: e4623.
35. Balasubramanian A, Ganju RK, Groopman JE, (2006) Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. Journal of Infectious Diseases 194: 670-681.
36. Gao B, (2005) Cytokines, STATs and liver disease. Cellular and Molecular Immunology 2: 92-100.
37. Balasubramanian A, Ganju R, Groopman J, (2003) HCV and HIV envelope proteins collaboratively mediate IL-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. Journal of Biological Chemistry 278: 35755-35766.
38. Polyak SJ, Khabar KS, Rezeiq M, Gretch D, (2001) Elevated levels of interleukin-8 in serum are associated with hepatitis C infection and resistance to interferon therapy. Journal of Virology 75: 6209-6211.
39. Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, et al. (2001) Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. Journal of Virology 75: 6095-6106.
40. Khabar KS, Al-Zoghaibi F, Al-Ahdal MN, Murayama T, Dhalla M, et al. (1997) The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon a. Journal of Experimental Medicine 186: 1077-1085.
41. Shrivastava A, Manna SK, Ray R, Aggarwal B, (1998) Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. Journal of Virology 72: 9722-9728.
42. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee Y, (1993) Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. Journal of Virology 67: 5823-5832.
43. Ray RB, Lagging LM, Meyer K, Steele R, Ray R, (1995) Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Research 37: 209-220.
44. Srinivas RV, Ray RB, Meyer K, Ray R, (1996) Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Research 45: 87-92.
45. Osborn L, Kunkel S, Nabel G, (1989) Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proceedings of the National Academy of Sciences (USA) 86: 2336-2340.
46. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, et al. (1997) Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Digestive Diseases & Sciences 42: 2487-2494.
47. Tawadrous GA, Aziz AA, Amin DG, Eldemery A, Mostafa M, (2012) RANTES, TNF-α, oxidative stress, and hematological abnormalities in hepatitis C virus infection. Journal of Investigative Medicine 60: 878-882.
48. Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, et al. (2005) Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. Journal of Virology 79: 13963-13973.
49. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Medicine 11: 791-796.
50. Frankel A, Pabo C, (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell Death and Differentiation 55: 118-1193.
51. Connor RI, Chen BK, Choe S, Landau N, (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206: 935-944.
52. He J, Choe S, Walker R, Di Marzio P, Morgan DO, et al. (1995) Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. Journal of Virology 69: 6705-6711.
53. Suzuki R, Tamura K, Li J, Ishii K, Matsuura Y, et al. (2001) Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus. Virology 280: 301-309.
54. Lindenbach B, (2009) Measuring HCV infectivity produced in cell culture and in vivo. Methods in Molecular Biology 510: 329-336.
55. Bessho R, Matsubara K, Kubota M, Kuwakado K, Hirota H, et al. (1994) Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochemical Pharmacology 48: 1883-1889.
56. Osborn L, Kunkel S, Nabel G, (1989) Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proceedings of the National Academy of Science USA. 86: 2336-2340.
57. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson A, (1989) Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proceedings of the National Academy of Science USA 86: 5974-5978.
58. Murakami K, Kimura T, Osaki M, Ishii K, Miyamura T, et al. (2008) Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines. Journal of General Virology 89: 1587-1592.
59. Blackard JT, Smeaton L, Hiasa Y, Horiike N, Onji M, et al. (2005) Detection of hepatitis C virus (HCV) in serum and peripheral blood mononuclear cells of HCV-monoinfected and HIV/HCV-coinfected persons. Journal of Infectious Diseases 192: 258-265.
60. Laskus T, Radkowski M, Jablonska J, Kibler K, Wilkinson J, et al. (2004) Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. Blood 103: 3854-3859.
61. Laskus T, Radkowski M, Wang L, Cianciara J, Vargas H, et al. (1997) Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear cells and viral sequences are identical to those in serum: a case against extrahepatic replication. Journal of General Virology 78: 2747-2750.
62. Laskus T, Radkowski M, Wang L, Vargas H, Rakela J, (1998) The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. Journal of Infectious Diseases 178: 1189-1192.
63. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, et al. (1996) Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. Journal of Clinical Investigation 97: 845-851.
64. Lerat H, Rumin S, Habersetzer F, Berby F, Trabaud M, et al. (1998) In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91: 3841-3849.
65. Radkowski M, Wang LF, Vargas HE, Rakela J, Laskus T, (1998) Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation 66: 664-666.
66. Revie D, Braich RS, Bayles D, Chelyapov N, Khan R, et al. (2005) Transmission of human hepatitis C virus from patients in secondary cells for long term culture. Virology Journal 2: 37.
67. Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, et al. (2000) Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World Journal of Gastroenterology. 6: 805-811.
68. Pizzella T, Banerjee R, (1994) Identification of a human immunodeficiency virus type 1 TAR binding protein in human hepatoblastoma HepG2 cells that trans-activates HIV-1 LTR-directed gene expression. DNA Cell Biology 13: 67-74.
69. Zhu M, Duan L, Pomerantz R, (1996) TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells. AIDS Research & Human Retroviruses 12: 1093-1101.
70. Gupta N, Sood V, Bano AS, Banerjea A, (2007) X Protein of hepatitis B virus potently activates HIV-1 subtype C long terminal repeat promoter: implications for faster spread of HIV-1 subtype C. AIDS. 21: 1491-1492.
71. Sato Y, Kato J, Takimoto R, Takada K, Kawano Y, et al. (2006) Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut 55: 1801-1808.
72. You LR, Chen CM, Lee Y, (1999) Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. Journal of Virology 73: 1672-1681.
73. Mann EA, Stanford S, Sherman K, (2006) Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus Research 121: 51-57.
74. Ray RB, Steele R, Basu A, Meyer K, Majumder M, et al. (2002) Distinct functional role of Hepatitis C virus core protein on NF-kappaB regulation is linked to genomic variation. Virus Research 87: 21-29.
75. Guitart A, Riezu-Boj JI, Elizalde E, Larrea E, Berasain C, et al. (2005) Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-kappaB nuclear translocation. Journal of General Virology 86: 3065-3074.
76. Gong G, Waris G, Tanveer R, Siddiqui A, (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proceedings of the National Academy of Science USA. 98: 9599-9604.
77. Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M, (1997) Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. Journal of Virology 71: 8856-8859.
78. Waris G, Livolsi A, Imbert V, Peyron JF, Siddiqui A, (2003) Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. Journal of Biological Chemistry 278: 40778-40787.
79. Hassan M, Selimovic D, Ghozlan H, Abdel-Kader O, (2007) Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation. Cellular Signalling 19: 301-311.
80. Wu X, Ishaq M, Hu J, Guo D, (2008) HCV NS3/4A protein activates HIV-1 transcription from its long terminal repeat. Virus Research 135: 155-160.
81. Kang L, Luo Z, Li Y, Zhang W, Sun W, et al. (2012) Association of Vpu with hepatitis C virus NS3/4A stimulates transcription of type 1 human immunodeficiency virus. Virus Research 163: 74-81.
82. De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, et al. (2002) Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Archives of Internal Medicine 162: 2125-2132.
83. Reiche EM, Bonametti AM, Morimoto HK, Morimoto AA, Wiechemann SL, et al. (2008) Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population. International Journal of Molecular Medicine 21: 387-395.
84. Shivraj SO, Chattopadhya D, Grover G, Kumar A, Baveja U, (2006) Role of HCV coinfection towards disease progression and survival in HIV-1 infected children: a follow-up study of 10 years. Journal of Tropical Pediatrics 52: 206-211.
85. Raboud J, Anema A, Su D, Klein MB, Zakaryan A, et al. (2012) Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy. HIV Clinical Trials 13: 90-102.